Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance
Clinical trial NCT04728035 · COMPLETED
Trial details
- NCT number
- NCT04728035
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-31
- Primary completion
- 2023-06-05
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.